about
Phosphorylation of recombinant human spermidine/spermine N(1)-acetyltransferase by CK1 and modulation of its binding to mitochondria: a comparison with CK2Catalase takes part in rat liver mitochondria oxidative stress defenseDesign, validation and efficacy of bisubstrate inhibitors specifically affecting ecto-CK2 kinase activity.Identification of the PLK2-dependent phosphopeptidome by quantitative proteomics [corrected].Effects of polyamines on mitochondrial Ca(2+) transport.Tools to discriminate between targets of CK2 vs PLK2/PLK3 acidophilic kinases.The biological functions of polyamine oxidation products by amine oxidases: perspectives of clinical applications.Tyrosine phosphorylation in mitochondria: a new frontier in mitochondrial signaling.Features and potentials of ATP-site directed CK2 inhibitors.The physiological role of biogenic amines redox reactions in mitochondria. New perspectives in cancer therapy.Mitochondrial tyrosine phosphoproteome: new insights from an up-to-date analysis.Receptor tyrosine kinases take a direct route to mitochondria: an overview.A Comparative Analysis and Review of lysyl Residues Affected by Posttranslational ModificationsFam20C is under the control of sphingolipid signaling in human cell lines.Dissecting the Role of K61/K59 Residue in VPS4 Functions.Exploring the CK2 Paradox: Restless, Dangerous, Dispensable.Programmed cell death protein 5 (PDCD5) is phosphorylated by CK2 in vitro and in 293T cells.Extraordinary pleiotropy of protein kinase CK2 revealed by weblogo phosphoproteome analysis.Protein kinase CK2 phosphorylates and upregulates Akt/PKB.Variable contribution of protein kinases to the generation of the human phosphoproteome: a global weblogo analysis.CK2 is a key regulator of SLC4A2-mediated Cl-/HCO3- exchange in human airway epithelia.Generation and quantitative proteomics analysis of CK2α/α'(-/-) cells.Agmatine is transported into liver mitochondria by a specific electrophoretic mechanism.CK2 involvement in ESCRT-III complex phosphorylation.Motif analysis of phosphosites discloses a potential prominent role of the Golgi casein kinase (GCK) in the generation of human plasma phospho-proteome.Aroclor 1254 inhibits the mitochondrial permeability transition and release of cytochrome c: a possible mechanism for its in vivo toxicity.Investigation on PLK2 and PLK3 substrate recognition.The effect of methylglyoxal-bis(guanylhydrazone) on mitochondrial Ca(2+) fluxes.Tyramine and monoamine oxidase inhibitors as modulators of the mitochondrial membrane permeability transition.Peroxovanadate inhibits Ca2+ release from mitochondria.Interaction of genistein with the mitochondrial electron transport chain results in opening of the membrane transition pore.Reciprocal effects between spermine and Mg2+ on their movements across the mitochondrial membrane.Glycyrrhetinic acid-induced permeability transition in rat liver mitochondria.Membrane binding and transport of N-aminoethyl-1,2-diamino ethane (dien) and N-aminopropyl-1,3-diamino propane (propen) by rat liver mitochondria and their effects on membrane permeability transition.Gliotoxin induces Mg2+ efflux from intact brain mitochondria.Menadione induces a low conductance state of the mitochondrial inner membrane sensitive to bongkrekic acid.Quantitative analysis of a phosphoproteome readily altered by the protein kinase CK2 inhibitor quinalizarin in HEK-293T cells.Carbenoxolone induces oxidative stress in liver mitochondria, which is responsible for transition pore opening.Analysis of tyrosine-phosphorylated proteins in rat brain mitochondria.Oxidative stress is responsible for mitochondrial permeability transition induction by salicylate in liver mitochondria.
P50
Q28214660-280B773D-1FE5-46E1-88DE-6D76CA4620FCQ28583748-6D111ADA-452A-4243-A3B1-913DA978FC9FQ30992224-9C9B53BA-B0AC-4AA8-A123-4434974A41ACQ35358750-9B150FB3-3C13-46EE-B0C9-0E6BBD8AAD97Q35683643-3EC8F991-2DE5-4545-AEC5-28B9DD616473Q35755416-8CA09250-1E15-4755-BA3C-5A431D58FE8DQ35981204-6BC9288E-FAE8-4202-B010-D4322D652C39Q36108162-3F02DE49-1C17-4882-9309-0898A3177613Q36273845-826FC3DB-C7F1-403E-8E3F-39E6A5AF2F77Q36772432-79746F80-8F44-4FE1-A54C-4594D9C5DDC1Q37809002-D2216BEF-E989-41BB-A360-CF96678C86D6Q38150885-5E81FA06-1A20-4981-BBCB-2C08CF1463DFQ38530761-08E3F2D7-CB32-44A7-A7FE-B3553A04C861Q38714897-1D88B419-9E13-4221-9A79-5B06F62923DFQ38782262-8664C2B7-152F-473D-8997-BFD8FCF0E003Q39100833-4271ED07-1BE5-4D8E-B185-F70DF8A2A317Q39823568-7F521289-4BC0-475D-A72C-E2B26B72A34AQ39865490-14DFA503-326B-4258-A11C-58A5303BC4A7Q40437202-31CADA10-731C-4E20-9FF4-D88057D56141Q40952550-158118F4-7B5A-49F4-A14E-43B14C9310E9Q41368424-8FEE23E5-61A9-4533-B249-6EDB05CE20CDQ41835528-60F0FCC3-72A0-43ED-8444-991EF22C5F72Q42156144-477EA8DE-69C2-4877-8F40-E472697DF07DQ42242492-B29A2CDF-04E9-4C7A-979C-4C7C9328A9CAQ43419704-53B68191-44D9-415E-8010-C9DB0C3176B2Q43767379-11A8E139-7AA1-4B6D-BCBE-84596D4AC71DQ43861296-01FC46C6-E7FE-4D0E-82B2-4E13B20EBF4DQ43883986-000D6AAE-EDC5-4927-A768-70DFAF1949BBQ44097921-75A497A9-F8A7-4443-93AA-3F12DE9FD582Q44132096-DCB80D75-26BD-44D6-BE3C-51D077A0D6C8Q44235479-1C9E3884-4579-4D91-B198-5D4959A901D2Q44353042-4D4E098B-23F8-40C9-AA75-B35A079E2D88Q44668657-49EC0345-54FD-486F-B1DA-A1216ACC78BBQ44942114-218E8F5D-0E02-4D3E-B70A-6EBFCCB75BC9Q44963700-C444569E-1D65-454D-97AC-1440EC5EEEFBQ45035672-AEC8A9AE-398A-45C0-89F0-7C0D72E25FE6Q45125178-E528FC6B-E346-49AD-953A-E4DFA28AA68BQ45242302-B3AD9D72-E9B2-496D-AC72-6FD817649522Q46019693-87F1B294-F732-4E7D-AA89-6B6C809181B9Q46650276-E15D6B81-01D7-4647-9755-B935837C07C9
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Mauro Salvi
@ast
Mauro Salvi
@en
Mauro Salvi
@es
Mauro Salvi
@nl
Mauro Salvi
@sl
type
label
Mauro Salvi
@ast
Mauro Salvi
@en
Mauro Salvi
@es
Mauro Salvi
@nl
Mauro Salvi
@sl
prefLabel
Mauro Salvi
@ast
Mauro Salvi
@en
Mauro Salvi
@es
Mauro Salvi
@nl
Mauro Salvi
@sl
P106
P1153
7006487881
P21
P31
P496
0000-0003-3448-6048